The U.S. Food and Drug Administration's Premarket Tobacco Product Application (PMTA) pathway is the most rigorous regulatory process that any e-liquid brand must navigate to achieve or maintain legal marketing authorization in the United States. For flavored e-liquid products specifically — which represent the overwhelming majority of consumer preference — the PMTA's evidentiary requirements around flavor ingredient documentation, aerosol characterization, toxicological assessment, and youth-risk demonstration create a compliance challenge that is substantially determined by the quality of documentation and data provided by the flavor concentrate supplier.On March 11, 2026, the FDA issued its landmark draft guidance document: 'Flavored Electronic Nicotine Delivery Systems (ENDS) Premarket Applications — Considerations Related to Youth.' Published in the Federal Register on March 11, 2026 (Federal Register 2026-04732), this draft guidance represents the most significant regulatory development in flavored PMTA review since the September 2020 submission deadline. It formally articulates the FDA's analytical framework for evaluating flavored ENDS applications, providing the clearest guidance yet on what documentation and evidence manufacturers must submit to achieve market authorization.This article explains the PMTA process as it applies to flavor ingredients following the 2026 draft guidance, what documentation the FDA now requires from flavor suppliers, how the Flavor Master File mechanism works, and how Cuiguai Flavor's comprehensive PMTA support package provides the foundation data that successful applications depend upon.
1. 美国PMTA流程：2026年监管背景
1.1 PMTA 的权威和法律框架
The FDA's authority to require premarket review of tobacco products — including e-cigarettes — derives from the Family Smoking Prevention and Tobacco Control Act (TCA) of 2009, which granted the FDA jurisdiction over the manufacture, distribution, and marketing of tobacco products under the Federal Food, Drug, and Cosmetic Act. The TCA established that any tobacco product not commercially marketed in the United States before February 15, 2007 (the 'predicate date') is a new tobacco product that requires premarket authorization before it can be legally sold.E-cigarettes and e-liquid products are classified as tobacco products under FDA's deeming authority (21 CFR Part 1100, finalized 2016). The initial PMTA submission deadline for deemed tobacco products was extended to September 9, 2020 — after which products lacking submitted PMTAs or marketing authorization became subject to enforcement action. Since the 2020 deadline, FDA has issued enforcement priorities and taken marketing denial orders (MDOs) against numerous products while advancing review of submitted applications.
1.2 2026 年 3 月指南草案：框架定义发展
The FDA's March 11, 2026 draft guidance on Flavored ENDS PMTAs represents the most substantive policy statement on flavored product applications since the agency's original PMTA guidance. As analyzed by Buchanan Ingersoll & Rooney (BIPC, March 17, 2026), the guidance 'sets forth how FDA will evaluate PMTA submissions for flavored ENDS products, with a specific focus on flavorings that appeal to youth.'The Tobacco Law Blog's analysis (March 23, 2026) described the guidance as describing 'FDA's perspective on PMTAs for flavored e-cigarettes' — formally articulating the evidentiary standard that FDA applies in reviewing flavored product applications. The draft guidance introduces a structured 'benefit-risk framework' for flavored ENDS applications, requiring applicants to demonstrate that the expected benefit to adult smokers (expressed as benefit-in-use) is commensurate with the expected risk of youth initiation or continued use.2026 年 3 月指南草案中与风味成分文件相关的主要条款：
截至 2026 年中期，FDA 仅通过 PMTA 途径授权了有限的调味 ENDS 产品。联盟对 FDA 指南草案的评论（美国牙科协会等人，2026 年 5 月 11 日）证实，截至 2026 年 3 月指南草案发布，FDA 仅授权了两种调味 ENDS 品牌——NJOY 薄荷醇和 JUUL 薄荷醇——均属于薄荷醇类别。截至 2026 年中期，没有任何水果、糖果、甜点或非烟草风味产品获得 PMTA 授权。This authorization landscape reflects FDA's current position that the available evidence base most readily supports the benefit-risk analysis for menthol and tobacco adjacent products — where the harm reduction benefit for combustible cigarette smokers transitioning to vaping is most established. It does not mean that fruit and other characterizing flavor products cannot achieve authorization; it means they face a higher evidentiary burden and require more comprehensive application packages.
2. FDA 对 PMTA 中风味成分的检查内容
2.1 成分身份和纯度文件
The foundational layer of flavor documentation in any PMTA is complete identification and purity characterization of all flavor ingredients present in the product. FDA's review examines:
Complete compound-level identification: each flavor ingredient must be identified by chemical name, CAS registry number, and concentration — not just brand trade names or generic 'natural flavor' designations. Generic designations are insufficient for PMTA review because they do not allow FDA to evaluate compound-specific safety data
FEMA GRAS status: for each flavor compound, applicants should identify whether the compound is classified as Generally Recognized As Safe by the Flavor and Extract Manufacturers Association (FEMA) — this classification is relevant but not determinative for FDA's safety evaluation, since FEMA GRAS addresses food applications not inhalation
成品中的浓度：每种风味成分的浓度占成品电子烟液配方的百分比，使 FDA 能够计算消费者在典型使用模式下的暴露量
2.2 加热态气溶胶表征：关键要求
PMTA 应用中技术要求最高的风味记录要求是加热态气溶胶表征，即对电子烟液在实际设备操作条件下蒸发时产生的化合物进行分析。这一要求远远超出了记录液体成分的范围；它需要表征实际吸入的化合物。FDA's review of aerosol chemistry identifies several key concerns:
For each flavor compound identified in the aerosol above the analytical reporting threshold, FDA's PMTA review expects toxicological characterization relevant to the inhalation route of exposure. This is a substantive evidentiary requirement that distinguishes PMTA flavor documentation from both food-use safety data and general chemical safety assessments.具体来说，FDA 寻找：
The Flavor Master File mechanism — drawn by analogy from the FDA's Drug Master File (DMF) framework in pharmaceutical regulation — enables flavor concentrate manufacturers to submit comprehensive proprietary formulation and safety documentation directly to the FDA. The PMTA applicant then references the Flavor Master File in their application, allowing FDA to access the complete flavor documentation without requiring the applicant to disclose trade-secret formulation information in their own filing.This mechanism is critical for the B2B e-liquid market because brand customers purchasing flavor concentrates from suppliers typically do not have independent access to the complete compound-by-compound formulation of those concentrates — which constitutes the supplier's core intellectual property. Without the Flavor Master File mechanism, applicants would face an impossible choice: either disclose the supplier's proprietary formulation in their public PMTA filing, or submit an incomplete application lacking the compound-level ingredient data FDA requires.The Flavor Master File resolves this tension: the supplier submits the complete proprietary formulation directly to FDA under a confidentiality framework; the applicant's PMTA references the Master File submission; FDA can access the complete data for review purposes without it being disclosed in the applicant's publicly available filing.
3.2 完整的风味主文件包含哪些内容
用于 PMTA 支持目的的完整风味主文件应包含：
A 部分（行政）：风味主文件持有者身份和联系信息；授权声明允许 FDA 在指定 PMTA 申请中交叉引用提交内容；主文件内容索引
B 部分（完整成分披露）：风味浓缩物的完整化合物配方； CAS 编号、系统化学名称和每种成分的浓度；每种风味化合物的 FEMA GRAS 状态；适用框架下的监管状态（FDA 21 CFR 182/184 食品添加剂状态；REACH 状态（如果相关））
C 部分（分析表征）：记录浓缩物化合物概况的 GC-MS 分析报告；批次间的一致性数据证明制造的可重复性；通过经过验证的分析方法测定二乙酰和乙酰丙酰含量；分析方法描述和验证总结
D 部分（热稳定性和气溶胶）：在代表性汽化温度下识别热转变产物的加热状态表征数据；液体与气溶胶化合物分布的比较分析；识别液体中不存在的在汽化温度下出现的任何新化合物
E 部分（毒理学摘要）：对于气溶胶中高于报告阈值的每种化合物：FEMA GRAS 状态、可用的吸入毒理学文献摘要以及 NSRL 比较（如果适用）；识别缺乏吸入特定数据的化合物，需要申请人方进行风险评估
F 部分（制造质量）：分析证书规格范围；生产设施GMP认证（ISO22000、HACCP）；制造工艺描述足以供 FDA 评估质量体系的充分性
3.3 PMTA 申请策略中的申请人与供应商关系
The Flavor Master File mechanism establishes a specific strategic relationship between the PMTA applicant (the e-liquid brand) and the flavor concentrate supplier. From the brand customer's perspective, the ideal supplier relationship provides:
Pre-filing Master File submission: the supplier submits the Flavor Master File to FDA before or concurrent with the brand's PMTA submission, ensuring FDA has access to the flavor documentation when it begins reviewing the application
申请人授权书：供应商出具的正式信件，授权 FDA 在品牌客户指定的 PMTA 申请中交叉引用主文件
Concurrent applicant access: where the supplier provides direct copies of the documentation to the brand applicant (subject to confidentiality protections), enabling the applicant's regulatory team to review the data and incorporate relevant elements into their application's safety section
4. Cuiguai Flavor's PMTA Support Documentation Package
Guangdong Unique Flavor Co., Ltd. (Cuiguai Flavor) has developed a comprehensive PMTA support documentation package specifically designed to provide the data FDA requires for flavor ingredient review in PMTA applications. Our package is structured to address each layer of the FDA's 2026 draft guidance requirements.
FEMA GRAS status annotation: for each flavor compound, explicit identification of FEMA GRAS status — including FEMA GRAS number where applicable — supporting the applicant's safety characterization section
FDA 21 CFR status annotation: identification of each compound's status under FDA's Generally Recognized As Safe (GRAS) and prior-sanctioned substance listings under 21 CFR Parts 182, 184, and 186
通过验证的分析方法在等效定量限下测定乙酰丙酰（2,3-戊二酮）含量：解决与 FDA 审查相关的完整二酮化合物类别
批次间一致性比较：三个或更多生产批次的 GC-MS 叠加比较，证明配方重现性和制造一致性
分析方法描述：以足以进行 FDA 方法验证评估的详细程度描述了 GC 条件、色谱柱规格、MS 参数、校准方法和定量方法
4.3 热稳定性表征
In response to the FDA's heated-state aerosol characterization requirement — which represents the most technically demanding element of the 2026 draft guidance — Cuiguai Flavor provides thermal stability data for priority concentrate products:
Based on the FDA's March 2026 draft guidance requirements and the full PMTA review framework, the following checklist represents the flavor documentation that PMTA applicants should request from their flavor concentrate suppliers as a minimum standard:
文档项目
FDA PMTA 目的
翠怪标准
完整成分披露 (FIDO)
用于气溶胶表征和毒理学评估的化合物级鉴定
每种产品均标配
批量 GC-MS 分析
化合物定量；二乙酰/二酮筛选；制造一致性数据
每批均符合标准
无二乙酰认证
优先考虑化合物安全问题； FDA 指南草案明确要求
标准;特定批次认证
热稳定性数据
气溶胶在汽化温度下的热态表征
可根据要求提供优先产品
FEMA GRAS 状态报告
风味化合物安全表征； FDA评估参考点
包含在 FIDO 文档中
批次间一致性数据
制造再现性演示
可根据要求提供（3 批次比较）
分析报告（COA）
物理/化学规格验证；批次可追溯性
每批均符合标准
安全数据表（SDS）
符合 GHS 的危险特征描述； OSHA 29 CFR 合规性
标准;英文GHS格式
风味主文件提交
保密配方可用于 FDA 审查，无需公开披露
根据要求为符合资格的 PMTA 客户提供
申请人授权书
FDA 交叉引用授权可在主文件和 PMTA 之间建立链接
提供风味主文件提交
6. 具体风味类别和 PMTA 策略
6.1 烟草和薄荷醇：授权途径
Based on FDA's authorization history (NJOY menthol and JUUL menthol as the only authorized flavored ENDS brands as of mid-2026) and the March 2026 draft guidance's articulation of the benefit-risk framework, tobacco-flavor and menthol-flavor products represent the most commercially viable PMTA authorization pathway in the current regulatory environment.对于烟草味产品，效益-风险分析是最直接可支持的：吸烟者转向烟草味电子烟产品的减少危害的好处在已发表的文献中已得到充分证实，而且青少年开始使用烟草味的风险明显低于具有明显吸引年轻人的感官特征的口味。我们全面的烟草香精浓缩物产品组合——涵盖弗吉尼亚、白肋烟、东方和天然烟丝特性——为 PMTA 申请人提供了建立引人注目的烟草特性产品线所需的品种深度。有关详细的产品信息和 PMTA 文档可用性，请参阅： Tobacco Flavor Concentrate — 以完整的 FIDO、COA、SDS 和 GC-MS 文件为标准，同时支持第 20 条通知和 PMTA 备案。
6.2 薄荷醇：桥梁类别
薄荷味产品在 PMTA 领域占据着重要的战略地位：它们是唯一获得 PMTA 授权成功的特色风味类别（NJOY 和 JUUL 薄荷醇），同时也是支持可燃卷烟转型最有力证据的类别——薄荷卷烟吸烟者占美国烟草使用者群体的很大一部分，而薄荷醇电子烟产品在这一细分市场中发挥着关键的过渡作用。For menthol PMTA applications, the benefit-risk balance is more favorable than for fruit or candy characterizing flavors — but still requires substantive documentation of menthol's role in the applicant's harm reduction narrative and evidence of marketing restriction measures limiting youth access.我们的 Cool Flavor Concentrate — available in both natural menthol and WS-23 cooling agent variants, with adjustable cooling intensity — supports menthol PMTA applications with full FIDO documentation, thermal stability data, and diacetyl-free certification as standard. Concentration specifications are designed for use within the FDA's PMTA-validated usage rate ranges.
有针对性的营销限制计划：限制分销、营销和包装的具体、可执行的承诺，以最大限度地减少青少年接触风险——并详细记录年龄验证系统、零售准入控制和在线销售限制，以供 FDA 评估
Adult smoker benefit evidence: studies specifically demonstrating that the characterizing flavor profile provides measurably greater harm reduction benefit to adult cigarette smokers than tobacco-flavor alternatives — addressing the 'incremental benefit above tobacco flavor' question that FDA implicitly raises in the characterizing flavor benefit-risk framework
问题 1：什么是 PMTA？为什么它对调味电子烟油很重要？A Premarket Tobacco Product Application (PMTA) is the FDA regulatory authorization pathway that e-cigarette products must complete to remain legally marketable in the United States. FDA's authority derives from the Tobacco Control Act (2009). Flavored e-liquid products that have not received FDA authorization technically lack market authorization — enforcement priority decisions determine immediate action, but the legal requirement is clear. The flavor documentation from the concentrate supplier is a critical component of any successful PMTA submission.问题 2：什么是风味主文件？它如何保护供应商商业秘密？A Flavor Master File enables a flavor concentrate manufacturer to submit comprehensive proprietary formulation and safety documentation directly to FDA, separate from the applicant's PMTA filing. The applicant references the Master File in their PMTA; FDA can access the complete confidential data for review purposes without it appearing in the applicant's public filing. This protects the supplier's trade-secret formulation information while giving FDA access to the compound-level data required for safety review.问题 3：2026 年 3 月 FDA 指南草案是什么？它改变了什么？On March 11, 2026, FDA issued the draft guidance 'Flavored Electronic Nicotine Delivery Systems (ENDS) Premarket Applications — Considerations Related to Youth' (Federal Register 2026-04732). This guidance formally articulated FDA's benefit-risk analytical framework for flavored ENDS applications, established flavor-specific documentation requirements, and clarified the evidentiary standards that differentiate tobacco/menthol applications from characterizing flavor applications. It represents the most significant FDA policy statement on flavored PMTA review since the 2020 submission deadline.问题 4：截至 2026 年，FDA 实际授权了哪些风味 ENDS 产品？As of mid-2026, FDA had authorized only two flavored ENDS brands: NJOY menthol and JUUL menthol — both in the menthol category. No fruit, candy, dessert, or other characterizing flavor products had received PMTA authorization. This reflects FDA's current benefit-risk assessment framework, which most readily supports authorization for tobacco-adjacent and menthol products where the adult harm reduction benefit is most directly documented.问题 5：对于 PMTA，我需要香料供应商提供哪些文件？At minimum: Full Ingredient Disclosure (FIDO) with CAS numbers and concentrations; batch GC-MS analysis with diacetyl/diketone screen; diacetyl-free certification; thermal stability characterization at vaporization temperatures; FEMA GRAS status documentation; batch-to-batch consistency data; Certificate of Analysis; and GHS-compliant Safety Data Sheet. For the Flavor Master File pathway, applicants also need the supplier's direct FDA submission and an applicant authorization letter.Q6：翠拐风味是否直接向FDA提交风味主文件？翠拐风味为我们的 B2B 客户提供全面的 PMTA 支持文档 — FIDO、GC-MS 分析、热稳定性数据、COA、SDS 和无二乙酰认证。对于正在申请的合格 PMTA 客户，我们可以开发风味主文件包，并协调 FDA 直接提交与申请人授权书。请联系我们的法规事务团队讨论您的具体 PMTA 文件要求和时间表。Q7：哪些香精品类获得PMTA授权前景最好？Based on FDA's authorization history and the March 2026 draft guidance framework, tobacco-flavor and menthol-flavor products have the clearest pathway to authorization. Characterizing flavors (fruit, candy, dessert) face a substantially higher evidentiary burden — requiring quantified youth initiation risk data, enforceable marketing restriction plans, and evidence of incremental adult smoker benefit beyond tobacco flavor. This does not make characterizing flavor authorization impossible, but it requires significantly more comprehensive application packages.Q8：如何向翠拐风味索取 PMTA 支持文档？通过 WhatsApp +86 189 2926 7983 或发送电子邮件至 info@cuiguai.com 联系我们的监管事务团队，并提供您的产品列表（您在我们的产品组合中使用的特定风味浓缩物）、您的 PMTA 提交时间表和目标风味类别。我们将根据您的应用要求提供完整的 PMTA 支持文档包，包括任何可用的热稳定性数据以及为符合条件的客户协调风味主文件开发。
8. 结论：文档质量作为 PMTA 策略
FDA 针对调味电子烟油产品的 PMTA 流程技术要求高、文档密集，并且越来越多地围绕 2026 年 3 月指南草案正式阐述的特定口味的利益风险框架进行构建。在这种环境下，浓缩物供应商提供的风味文档的质量不再是次要的管理考虑因素，而是 PMTA 申请成功的核心决定因素。无法提供其风味成分特征（液体、气雾剂和毒理学评估水平）的完整、精确和科学严谨的表征的申请，甚至在 FDA 达到效益-风险优点之前，就会因文件充分性而被拒绝。对于为 PMTA 申请人提供服务的 B2B 浓缩香料制造商来说，这种监管现实创造了一个直接的机会：通过提供 PMTA 申请所依赖的文档基础设施，成为战略合作伙伴，而不仅仅是成分来源。投资于综合 FIDO 文档系统、经过双乙酰认证的批量 GC-MS 协议、热稳定性表征和风味主文件提交功能的制造商将自己定位为最重视美国市场授权的品牌的首选供应商。The US e-cigarette market — valued at USD 8.39 billion in 2025 and projected to reach USD 18.05 billion by 2035 according to Precedence Research — represents an extraordinary commercial opportunity. For flavor concentrate suppliers whose documentation infrastructure enables their brand customers to achieve and maintain PMTA authorization, this opportunity is accessible. For those whose documentation falls short of FDA's requirements, the US market becomes increasingly difficult to serve as enforcement priorities evolve.
翠拐PMTA-Ready Manufacturing
Build Your PMTA Application with Cuiguai Flavor's Complete Documentation Package
广东独特香料有限公司（翠拐香料）是一家专业的电子烟油浓缩香料制造商，总部位于中国广东省东莞市。我们的 PMTA 支持包提供 FDA 风味成分审查所需的完整文档基础：FIDO、具有无二乙酰认证的批量 GC-MS、热稳定性表征、COA 和符合 GHS 的 SDS。风味主文件开发可供符合资格的 PMTA 客户使用。 ISO22000 / ISO9001 / HACCP 认证。 20,000 多个预先开发的配方。 24小时样品发送。技术咨询和 PMTA 文件请求：网站: https://www.cuiguai.com电子邮件：info@cuiguai.com电话：+86 0769 88380789WhatsApp & Telegram: +86 189 2926 7983参考文献[1] 美国食品和药物管理局。 （2026 年 3 月 11 日）。调味电子尼古丁输送系统 (ENDS) 上市前应用 — 与青少年相关的注意事项（指南草案）。联邦公报 2026-04732。 https://www.fda.gov/regulatory-information/search-fda-guidance-documents/flavored-Electronic-nicotine-delivery-systems-ends-premarket-applications-considerations-lated[2] 联邦公报。 （2026 年 3 月 11 日）。调味 ENDS 上市前申请指南草案出版物。 https://www.federalregister.gov/documents/2026/03/11/2026-04732/flavored-electronic-nicotine-delivery-systems-ends-premarket-applications-considerations-lated-to[3] 烟草法博客。 （2026 年 3 月 23 日）。 FDA 发布有关调味 ENDS PMTA 的指南草案。 https://www.tobaccolawblog.com/2026/03/fda-issues-draft-guidance-on-flavored-ends-pmtas/[4] 布坎南·英格索尔和鲁尼 (BIPC)。 （2026 年 3 月 17 日）。 FDA 关于调味电子烟产品的新指南草案。 https://www.bipc.com/new-draft-guidance-from-fda-on-flavored-vape-products[5] 风险的连续体。 （2026 年 3 月 10 日）。随着青少年电子烟数量持续下降，FDA 正式制定了特定口味的 PMTA 框架。 https://www.thecontinuumofrisk.com/2026/03/fda-formalizes-a-flavor-specific-pmta-framework-as-youth-vaping-continues-to-decline/[6] American Dental Association et al. (May 11, 2026). Coalition Comments on FDA's Draft Industry Guidance for Flavored E-Cigarette PMTAs. Confirms only NJOY menthol and JUUL menthol authorized as of guidance issuance. https://www.ada.org/-/media/project/ada-organization/ada/ada-org/files/advocacy/healthy-behaviors/2026/260511_fda_tobacco_flavored_guidance_coalitio.pdf[7] 《家庭吸烟预防和烟草控制法》（Pub. L. 111-31，2009）。 FDA 根据 TCA 第 201(rr) 条对烟草产品（包括电子烟）的权力。[8]优先研究。 （2025）。美国电子烟和电子烟市场 — 83.9 亿美元（2025 年），预计到 2035 年将达到 180.5 亿美元。 https://www.precedenceresearch.com/e-香烟-market
